Lv1
56 积分 2022-07-19 加入
Cancer burden and control in China: landscape, trends and challenges
1个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
1个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
6个月前
已完结
Therapeutic strategies for sarcopenic obesity: a systematic review
7个月前
已完结
Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
7个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
7个月前
已完结
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
7个月前
已完结
The Phosphoinositide 3-Kinase Pathway
7个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
7个月前
已完结
Structural Insights into the Development of Inhibitors Against Cancer-Specific Mutations of PI3Kα
7个月前
已完结
皖公网安备34019202002308
